Literature DB >> 1830830

Leukocyte adhesion in host defense and tissue injury.

M Patarroyo1.   

Abstract

During their life span, leukocytes adhere transiently to one another, to other cell types, such as vascular endothelial cells, and to extracellular matrix proteins. This adhesiveness is mediated by families of specific cell surface adhesion molecules, namely, integrins, immunoglobulin superfamily molecules, and selectins. Adhesion is required for leukocyte-mediated cytotoxicity, phagocytosis, chemotaxis, and induction of lymphocyte proliferation and maturation. It also participates in recirculation and homing of lymphocytes into lymphoid organs and in leukocyte migration from the vascular compartment to extravascular tissues. Adhesion underlies the beneficial or detrimental role of leukocytes in immune and inflammatory responses. In animals, blocking monoclonal antibodies to adhesion molecules dramatically reduce vascular and tissue injury in several organs following ischemia-reperfusion, and delay renal allograft rejection. Moreover, expression of particular adhesion molecules is induced or increased in cells which are targets for allergic or autoimmune reactions and in inflamed tissues. On the other hand, a congenital deficiency of the CD11/CD18 integrins (Leu-CAMs) leads to recurrent, and sometimes fatal, bacterial infections, and lack of particular cell-adhesion molecules on Burkitt's lymphoma cells may enable these cells to escape immunosurveillance.

Entities:  

Mesh:

Year:  1991        PMID: 1830830     DOI: 10.1016/0090-1229(91)90091-n

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  11 in total

Review 1.  Leucocyte adhesion deficiency.

Authors:  M H el Habbal; S Strobel
Journal:  Arch Dis Child       Date:  1993-10       Impact factor: 3.791

2.  The effects of IB4, a monoclonal antibody to the CD18 leukocyte integrin on phorbol myristate acetate (PMA)-induced polymorphonuclear leukocyte (PMN) accumulation and endothelial injury in rabbit lungs.

Authors:  R D Meurer; M J Forrest; D E MacIntyre
Journal:  Inflammation       Date:  1999-02       Impact factor: 4.092

3.  Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat).

Authors:  J H Garcia; K F Liu; Y Yoshida; J Lian; S Chen; G J del Zoppo
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

4.  Flow cytometric approach to human polymorphonuclear leukocyte activation induced by gingival crevicular fluid in periodontal disease.

Authors:  R Biselli; C Ferlini; C Di Murro; M Paolantonio; A Fattorossi
Journal:  Inflammation       Date:  1995-08       Impact factor: 4.092

5.  Measles virus-induced changes in leukocyte function antigen 1 expression and leukocyte aggregation: possible role in measles virus pathogenesis.

Authors:  N Attibele; P R Wyde; J Trial; S C Smole; C W Smith; R D Rossen
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

6.  Expression of endothelial adhesion molecules in vivo. Increased endothelial ICAM-2 expression in lymphoid malignancies.

Authors:  R Renkonen; T Paavonen; P Nortamo; C G Gahmberg
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

7.  Evidence that measles virus hemagglutinin initiates modulation of leukocyte function-associated antigen 1 expression.

Authors:  A R Nagendra; C W Smith; P R Wyde
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

8.  Synergism among oxidants, proteinases, phospholipases, microbial hemolysins, cationic proteins, and cytokines.

Authors:  I Ginsburg; R Misgav; A Pinson; J Varani; P A Ward; R Kohen
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

9.  Effect of infection by lactic dehydrogenase virus on expression of intercellular adhesion molecule-1 on vascular endothelial cells of pancreatic islets in streptozotocin-induced insulitis of CD-1 mice.

Authors:  T Hayashi; S Hashimoto; A Kawashima
Journal:  Int J Exp Pathol       Date:  1994-06       Impact factor: 1.925

10.  Reduced streptozotocin-induced insulitis in CD-1 mice by treatment with anti-intercellular adhesion molecule-1 and anti-lymphocyte function associated antigen-1 monoclonal antibodies together with lactic dehydrogenase virus infection.

Authors:  T Hayashi; S Hashimoto; Y Kameyama
Journal:  Int J Exp Pathol       Date:  1994-04       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.